 | • レポートコード：MRC2-11QY02437 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は狭心症治療のグローバル市場について調査・分析したレポートです。種類別（抗血小板薬、ベータアドレナリン遮断薬、カルシウムチャネル遮断薬、短時間作用型・長時間作用型ニトログリセリン、アンジオテンシン変換酵素（ACE）阻害薬、抗虚血薬）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別狭心症治療の競争状況、市場シェア ・世界の狭心症治療市場：種類別市場規模 2015年-2020年（抗血小板薬、ベータアドレナリン遮断薬、カルシウムチャネル遮断薬、短時間作用型・長時間作用型ニトログリセリン、アンジオテンシン変換酵素（ACE）阻害薬、抗虚血薬） ・世界の狭心症治療市場：種類別市場規模予測 2021年-2026年（抗血小板薬、ベータアドレナリン遮断薬、カルシウムチャネル遮断薬、短時間作用型・長時間作用型ニトログリセリン、アンジオテンシン変換酵素（ACE）阻害薬、抗虚血薬） ・世界の狭心症治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の狭心症治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の狭心症治療市場分析：米国、カナダ ・ヨーロッパの狭心症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの狭心症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の狭心症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの狭心症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories Inc.、Astra Zeneca plc、Bayer AG、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd、Forest Laboratories Inc、Gilead Sciences, Inc、GlaxoSmithKline plc、Novartis AG、Pfizer Inc.、Sanofi SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Angina Pectoris Treatment Market
The global Angina Pectoris Treatment market size is projected to reach US$ 7908.5 million by 2026, from US$ 7756.3 million in 2020, at a CAGR of 1.8%% during 2021-2026.
Global Angina Pectoris Treatment Scope and Market Size
Angina Pectoris Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angina Pectoris Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Angina Pectoris Treatment market is segmented into
Antiplatelet agents
Beta-adrenergic blocking agents
Calcium channel blockers
Short & Long – acting Nitroglycerines
Angiotensin-converting enzyme (ACE) inhibitors
Anti-ischemic agents
Segment by Application, the Angina Pectoris Treatment market is segmented into
Hospitals
Clinic
Other
Regional and Country-level Analysis
The Angina Pectoris Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Angina Pectoris Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Angina Pectoris Treatment Market Share Analysis
Angina Pectoris Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angina Pectoris Treatment business, the date to enter into the Angina Pectoris Treatment market, Angina Pectoris Treatment product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories Inc.
Astra Zeneca plc
Bayer AG
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
Forest Laboratories Inc
Gilead Sciences, Inc
GlaxoSmithKline plc
Novartis AG
Pfizer Inc.
Sanofi SA
1 Study Coverage
1.1 Angina Pectoris Treatment Product Introduction
1.2 Market Segments
1.3 Key Angina Pectoris Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Angina Pectoris Treatment Market Size Growth Rate by Type
1.4.2 Antiplatelet agents
1.4.3 Beta-adrenergic blocking agents
1.4.4 Calcium channel blockers
1.4.5 Short & Long – acting Nitroglycerines
1.4.6 Angiotensin-converting enzyme (ACE) inhibitors
1.4.7 Anti-ischemic agents
1.5 Market by Application
1.5.1 Global Angina Pectoris Treatment Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Angina Pectoris Treatment Market Size, Estimates and Forecasts
2.1.1 Global Angina Pectoris Treatment Revenue 2015-2026
2.1.2 Global Angina Pectoris Treatment Sales 2015-2026
2.2 Global Angina Pectoris Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Angina Pectoris Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Angina Pectoris Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Angina Pectoris Treatment Competitor Landscape by Players
3.1 Angina Pectoris Treatment Sales by Manufacturers
3.1.1 Angina Pectoris Treatment Sales by Manufacturers (2015-2020)
3.1.2 Angina Pectoris Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Angina Pectoris Treatment Revenue by Manufacturers
3.2.1 Angina Pectoris Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Angina Pectoris Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Angina Pectoris Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Angina Pectoris Treatment Revenue in 2019
3.2.5 Global Angina Pectoris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Angina Pectoris Treatment Price by Manufacturers
3.4 Angina Pectoris Treatment Manufacturing Base Distribution, Product Types
3.4.1 Angina Pectoris Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angina Pectoris Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Angina Pectoris Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Angina Pectoris Treatment Market Size by Type (2015-2020)
4.1.1 Global Angina Pectoris Treatment Sales by Type (2015-2020)
4.1.2 Global Angina Pectoris Treatment Revenue by Type (2015-2020)
4.1.3 Angina Pectoris Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Angina Pectoris Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Angina Pectoris Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Angina Pectoris Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Angina Pectoris Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Angina Pectoris Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Angina Pectoris Treatment Market Size by Application (2015-2020)
5.1.1 Global Angina Pectoris Treatment Sales by Application (2015-2020)
5.1.2 Global Angina Pectoris Treatment Revenue by Application (2015-2020)
5.1.3 Angina Pectoris Treatment Price by Application (2015-2020)
5.2 Angina Pectoris Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Angina Pectoris Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Angina Pectoris Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Angina Pectoris Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Angina Pectoris Treatment by Country
6.1.1 North America Angina Pectoris Treatment Sales by Country
6.1.2 North America Angina Pectoris Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Angina Pectoris Treatment Market Facts & Figures by Type
6.3 North America Angina Pectoris Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Angina Pectoris Treatment by Country
7.1.1 Europe Angina Pectoris Treatment Sales by Country
7.1.2 Europe Angina Pectoris Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Angina Pectoris Treatment Market Facts & Figures by Type
7.3 Europe Angina Pectoris Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Angina Pectoris Treatment by Region
8.1.1 Asia Pacific Angina Pectoris Treatment Sales by Region
8.1.2 Asia Pacific Angina Pectoris Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Angina Pectoris Treatment Market Facts & Figures by Type
8.3 Asia Pacific Angina Pectoris Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Angina Pectoris Treatment by Country
9.1.1 Latin America Angina Pectoris Treatment Sales by Country
9.1.2 Latin America Angina Pectoris Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Angina Pectoris Treatment Market Facts & Figures by Type
9.3 Central & South America Angina Pectoris Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Angina Pectoris Treatment by Country
10.1.1 Middle East and Africa Angina Pectoris Treatment Sales by Country
10.1.2 Middle East and Africa Angina Pectoris Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Angina Pectoris Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Angina Pectoris Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott Laboratories Inc.
11.1.1 Abbott Laboratories Inc. Corporation Information
11.1.2 Abbott Laboratories Inc. Description and Business Overview
11.1.3 Abbott Laboratories Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Inc. Angina Pectoris Treatment Products Offered
11.1.5 Abbott Laboratories Inc. Related Developments
11.2 Astra Zeneca plc
11.2.1 Astra Zeneca plc Corporation Information
11.2.2 Astra Zeneca plc Description and Business Overview
11.2.3 Astra Zeneca plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astra Zeneca plc Angina Pectoris Treatment Products Offered
11.2.5 Astra Zeneca plc Related Developments
11.3 Bayer AG
11.3.1 Bayer AG Corporation Information
11.3.2 Bayer AG Description and Business Overview
11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer AG Angina Pectoris Treatment Products Offered
11.3.5 Bayer AG Related Developments
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Corporation Information
11.4.2 Bristol-Myers Squibb Company Description and Business Overview
11.4.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Company Angina Pectoris Treatment Products Offered
11.4.5 Bristol-Myers Squibb Company Related Developments
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd Description and Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Products Offered
11.5.5 F. Hoffmann-La Roche Ltd Related Developments
11.6 Forest Laboratories Inc
11.6.1 Forest Laboratories Inc Corporation Information
11.6.2 Forest Laboratories Inc Description and Business Overview
11.6.3 Forest Laboratories Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Forest Laboratories Inc Angina Pectoris Treatment Products Offered
11.6.5 Forest Laboratories Inc Related Developments
11.7 Gilead Sciences, Inc
11.7.1 Gilead Sciences, Inc Corporation Information
11.7.2 Gilead Sciences, Inc Description and Business Overview
11.7.3 Gilead Sciences, Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gilead Sciences, Inc Angina Pectoris Treatment Products Offered
11.7.5 Gilead Sciences, Inc Related Developments
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Corporation Information
11.8.2 GlaxoSmithKline plc Description and Business Overview
11.8.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc Angina Pectoris Treatment Products Offered
11.8.5 GlaxoSmithKline plc Related Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Description and Business Overview
11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis AG Angina Pectoris Treatment Products Offered
11.9.5 Novartis AG Related Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Corporation Information
11.10.2 Pfizer Inc. Description and Business Overview
11.10.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Inc. Angina Pectoris Treatment Products Offered
11.10.5 Pfizer Inc. Related Developments
11.1 Abbott Laboratories Inc.
11.1.1 Abbott Laboratories Inc. Corporation Information
11.1.2 Abbott Laboratories Inc. Description and Business Overview
11.1.3 Abbott Laboratories Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Inc. Angina Pectoris Treatment Products Offered
11.1.5 Abbott Laboratories Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Angina Pectoris Treatment Market Estimates and Projections by Region
12.1.1 Global Angina Pectoris Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Angina Pectoris Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Angina Pectoris Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Angina Pectoris Treatment Sales Forecast (2021-2026)
12.2.2 North America: Angina Pectoris Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Angina Pectoris Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Angina Pectoris Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Angina Pectoris Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Angina Pectoris Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Angina Pectoris Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Angina Pectoris Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Angina Pectoris Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Angina Pectoris Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Angina Pectoris Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Angina Pectoris Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Angina Pectoris Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Angina Pectoris Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Angina Pectoris Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Angina Pectoris Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angina Pectoris Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Angina Pectoris Treatment Market Segments
Table 2. Ranking of Global Top Angina Pectoris Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Angina Pectoris Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Antiplatelet agents
Table 5. Major Manufacturers of Beta-adrenergic blocking agents
Table 6. Major Manufacturers of Calcium channel blockers
Table 7. Major Manufacturers of Short & Long – acting Nitroglycerines
Table 8. Major Manufacturers of Angiotensin-converting enzyme (ACE) inhibitors
Table 9. Major Manufacturers of Anti-ischemic agents
Table 10. Global Angina Pectoris Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Angina Pectoris Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Angina Pectoris Treatment Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Angina Pectoris Treatment Sales Market Share by Regions (2015-2020)
Table 14. Global Angina Pectoris Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Angina Pectoris Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Angina Pectoris Treatment Sales Share by Manufacturers (2015-2020)
Table 17. Global Angina Pectoris Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Angina Pectoris Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angina Pectoris Treatment as of 2019)
Table 19. Angina Pectoris Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Angina Pectoris Treatment Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Angina Pectoris Treatment Price (2015-2020) (USD/Pcs)
Table 22. Angina Pectoris Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Angina Pectoris Treatment Product Type
Table 24. Date of International Manufacturers Enter into Angina Pectoris Treatment Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Angina Pectoris Treatment Sales by Type (2015-2020) (K Pcs)
Table 27. Global Angina Pectoris Treatment Sales Share by Type (2015-2020)
Table 28. Global Angina Pectoris Treatment Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Angina Pectoris Treatment Revenue Share by Type (2015-2020)
Table 30. Angina Pectoris Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Angina Pectoris Treatment Sales by Application (2015-2020) (K Pcs)
Table 32. Global Angina Pectoris Treatment Sales Share by Application (2015-2020)
Table 33. North America Angina Pectoris Treatment Sales by Country (2015-2020) (K Pcs)
Table 34. North America Angina Pectoris Treatment Sales Market Share by Country (2015-2020)
Table 35. North America Angina Pectoris Treatment Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Angina Pectoris Treatment Revenue Market Share by Country (2015-2020)
Table 37. North America Angina Pectoris Treatment Sales by Type (2015-2020) (K Pcs)
Table 38. North America Angina Pectoris Treatment Sales Market Share by Type (2015-2020)
Table 39. North America Angina Pectoris Treatment Sales by Application (2015-2020) (K Pcs)
Table 40. North America Angina Pectoris Treatment Sales Market Share by Application (2015-2020)
Table 41. Europe Angina Pectoris Treatment Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Angina Pectoris Treatment Sales Market Share by Country (2015-2020)
Table 43. Europe Angina Pectoris Treatment Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Angina Pectoris Treatment Revenue Market Share by Country (2015-2020)
Table 45. Europe Angina Pectoris Treatment Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Angina Pectoris Treatment Sales Market Share by Type (2015-2020)
Table 47. Europe Angina Pectoris Treatment Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Angina Pectoris Treatment Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Angina Pectoris Treatment Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Angina Pectoris Treatment Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Angina Pectoris Treatment Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Angina Pectoris Treatment Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Angina Pectoris Treatment Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Angina Pectoris Treatment Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Angina Pectoris Treatment Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Angina Pectoris Treatment Sales Market Share by Application (2015-2020)
Table 57. Latin America Angina Pectoris Treatment Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Angina Pectoris Treatment Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Angina Pectoris Treatment Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Angina Pectoris Treatment Revenue Market Share by Country (2015-2020)
Table 61. Latin America Angina Pectoris Treatment Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Angina Pectoris Treatment Sales Market Share by Type (2015-2020)
Table 63. Latin America Angina Pectoris Treatment Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Angina Pectoris Treatment Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Angina Pectoris Treatment Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Angina Pectoris Treatment Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Angina Pectoris Treatment Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Angina Pectoris Treatment Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Angina Pectoris Treatment Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Angina Pectoris Treatment Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Angina Pectoris Treatment Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Angina Pectoris Treatment Sales Market Share by Application (2015-2020)
Table 73. Abbott Laboratories Inc. Corporation Information
Table 74. Abbott Laboratories Inc. Description and Major Businesses
Table 75. Abbott Laboratories Inc. Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Abbott Laboratories Inc. Product
Table 77. Abbott Laboratories Inc. Recent Development
Table 78. Astra Zeneca plc Corporation Information
Table 79. Astra Zeneca plc Description and Major Businesses
Table 80. Astra Zeneca plc Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Astra Zeneca plc Product
Table 82. Astra Zeneca plc Recent Development
Table 83. Bayer AG Corporation Information
Table 84. Bayer AG Description and Major Businesses
Table 85. Bayer AG Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Bayer AG Product
Table 87. Bayer AG Recent Development
Table 88. Bristol-Myers Squibb Company Corporation Information
Table 89. Bristol-Myers Squibb Company Description and Major Businesses
Table 90. Bristol-Myers Squibb Company Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Bristol-Myers Squibb Company Product
Table 92. Bristol-Myers Squibb Company Recent Development
Table 93. F. Hoffmann-La Roche Ltd Corporation Information
Table 94. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 95. F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. F. Hoffmann-La Roche Ltd Product
Table 97. F. Hoffmann-La Roche Ltd Recent Development
Table 98. Forest Laboratories Inc Corporation Information
Table 99. Forest Laboratories Inc Description and Major Businesses
Table 100. Forest Laboratories Inc Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Forest Laboratories Inc Product
Table 102. Forest Laboratories Inc Recent Development
Table 103. Gilead Sciences, Inc Corporation Information
Table 104. Gilead Sciences, Inc Description and Major Businesses
Table 105. Gilead Sciences, Inc Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Gilead Sciences, Inc Product
Table 107. Gilead Sciences, Inc Recent Development
Table 108. GlaxoSmithKline plc Corporation Information
Table 109. GlaxoSmithKline plc Description and Major Businesses
Table 110. GlaxoSmithKline plc Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. GlaxoSmithKline plc Product
Table 112. GlaxoSmithKline plc Recent Development
Table 113. Novartis AG Corporation Information
Table 114. Novartis AG Description and Major Businesses
Table 115. Novartis AG Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Novartis AG Product
Table 117. Novartis AG Recent Development
Table 118. Pfizer Inc. Corporation Information
Table 119. Pfizer Inc. Description and Major Businesses
Table 120. Pfizer Inc. Angina Pectoris Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Pfizer Inc. Product
Table 122. Pfizer Inc. Recent Development
Table 123. Sanofi SA Corporation Information
Table 124. Sanofi SA Description and Major Businesses
Table 125. Sanofi SA Angina Pectoris Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Sanofi SA Product
Table 127. Sanofi SA Recent Development
Table 128. Global Angina Pectoris Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 129. Global Angina Pectoris Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Angina Pectoris Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Angina Pectoris Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Angina Pectoris Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. North America: Angina Pectoris Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Angina Pectoris Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Europe: Angina Pectoris Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Angina Pectoris Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 137. Asia Pacific: Angina Pectoris Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Angina Pectoris Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Latin America: Angina Pectoris Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Angina Pectoris Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. Middle East and Africa: Angina Pectoris Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Angina Pectoris Treatment Players
Table 146. Angina Pectoris Treatment Customers List
Table 147. Angina Pectoris Treatment Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Angina Pectoris Treatment Product Picture
Figure 2. Global Angina Pectoris Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Antiplatelet agents Product Picture
Figure 4. Beta-adrenergic blocking agents Product Picture
Figure 5. Calcium channel blockers Product Picture
Figure 6. Short & Long – acting Nitroglycerines Product Picture
Figure 7. Angiotensin-converting enzyme (ACE) inhibitors Product Picture
Figure 8. Anti-ischemic agents Product Picture
Figure 9. Global Angina Pectoris Treatment Sales Market Share by Application in 2020 & 2026
Figure 10. Hospitals
Figure 11. Clinic
Figure 12. Other
Figure 13. Angina Pectoris Treatment Report Years Considered
Figure 14. Global Angina Pectoris Treatment Market Size 2015-2026 (US$ Million)
Figure 15. Global Angina Pectoris Treatment Sales 2015-2026 (K Pcs)
Figure 16. Global Angina Pectoris Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Angina Pectoris Treatment Sales Market Share by Region (2015-2020)
Figure 18. Global Angina Pectoris Treatment Sales Market Share by Region in 2019
Figure 19. Global Angina Pectoris Treatment Revenue Market Share by Region (2015-2020)
Figure 20. Global Angina Pectoris Treatment Revenue Market Share by Region in 2019
Figure 21. Global Angina Pectoris Treatment Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Angina Pectoris Treatment Revenue in 2019
Figure 23. Angina Pectoris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Angina Pectoris Treatment Sales Market Share by Type (2015-2020)
Figure 25. Global Angina Pectoris Treatment Sales Market Share by Type in 2019
Figure 26. Global Angina Pectoris Treatment Revenue Market Share by Type (2015-2020)
Figure 27. Global Angina Pectoris Treatment Revenue Market Share by Type in 2019
Figure 28. Global Angina Pectoris Treatment Market Share by Price Range (2015-2020)
Figure 29. Global Angina Pectoris Treatment Sales Market Share by Application (2015-2020)
Figure 30. Global Angina Pectoris Treatment Sales Market Share by Application in 2019
Figure 31. Global Angina Pectoris Treatment Revenue Market Share by Application (2015-2020)
Figure 32. Global Angina Pectoris Treatment Revenue Market Share by Application in 2019
Figure 33. North America Angina Pectoris Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Angina Pectoris Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Angina Pectoris Treatment Sales Market Share by Country in 2019
Figure 36. North America Angina Pectoris Treatment Revenue Market Share by Country in 2019
Figure 37. U.S. Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Angina Pectoris Treatment Market Share by Type in 2019
Figure 42. North America Angina Pectoris Treatment Market Share by Application in 2019
Figure 43. Europe Angina Pectoris Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Angina Pectoris Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Angina Pectoris Treatment Sales Market Share by Country in 2019
Figure 46. Europe Angina Pectoris Treatment Revenue Market Share by Country in 2019
Figure 47. Germany Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Angina Pectoris Treatment Market Share by Type in 2019
Figure 58. Europe Angina Pectoris Treatment Market Share by Application in 2019
Figure 59. Asia Pacific Angina Pectoris Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Angina Pectoris Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Angina Pectoris Treatment Sales Market Share by Region in 2019
Figure 62. Asia Pacific Angina Pectoris Treatment Revenue Market Share by Region in 2019
Figure 63. China Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Angina Pectoris Treatment Market Share by Type in 2019
Figure 86. Asia Pacific Angina Pectoris Treatment Market Share by Application in 2019
Figure 87. Latin America Angina Pectoris Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Angina Pectoris Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Angina Pectoris Treatment Sales Market Share by Country in 2019
Figure 90. Latin America Angina Pectoris Treatment Revenue Market Share by Country in 2019
Figure 91. Mexico Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Angina Pectoris Treatment Market Share by Type in 2019
Figure 98. Latin America Angina Pectoris Treatment Market Share by Application in 2019
Figure 99. Middle East and Africa Angina Pectoris Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Angina Pectoris Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Angina Pectoris Treatment Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Angina Pectoris Treatment Revenue Market Share by Country in 2019
Figure 103. Turkey Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Angina Pectoris Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Angina Pectoris Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Angina Pectoris Treatment Market Share by Type in 2019
Figure 110. Middle East and Africa Angina Pectoris Treatment Market Share by Application in 2019
Figure 111. North America Angina Pectoris Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Angina Pectoris Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Angina Pectoris Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Angina Pectoris Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Angina Pectoris Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Angina Pectoris Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Angina Pectoris Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Angina Pectoris Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Angina Pectoris Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Angina Pectoris Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
狭心症治療薬の世界市場（～2026年） Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as - stable, unstable, microvascular and Prinzmetal / variant. A…- 虚血性心疾患（IHD）薬の世界市場（～2026年） Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…
- バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
- 固結防止剤の世界市場（～2026年） Anti-caking agents are utilized to prevent the formation of lumps, mostly in finely powdered substances. Anti-caking agents are soluble in alcohol, water and other organic solvents. They either absorb excess moisture or create a water-repellent coating on the powdered particles. Asia Pacific is expe…
- 肉たたき剤の世界市場（～2026年） Tenderness is a quality of meat gauging how easily it is chewed or cut. Tenderness is a desirable quality, as tender meat is softer, easier to chew, and generally more palatable than harder meat. Consequently, tender cuts of meat typically command higher prices. The tenderness depends on a number of…